MyAverix Finance
ST · General
Oncopeptides AB (ONCO)
Diversified
Oncopeptides AB (ONCO) is listed on ST in the General sector. Industry: Diversified. As of 2026-05-24, reported market cap is $623.18M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ONCO
Oncopeptides AB (ONCO) — FAQ
What is Oncopeptides AB's market cap?
Oncopeptides AB (ONCO) has a reported market cap of $623.18M (data as of 2026-05-24).
What is ONCO's P/E ratio?
The price-to-earnings (P/E) ratio for Oncopeptides AB (ONCO) is 18.00 (data as of 2026-05-24).
Does Oncopeptides AB pay a dividend?
Dividend yield is not available in the current snapshot for Oncopeptides AB (ONCO). Check the MyAverix Finance app for the latest dividend data.
What sector is Oncopeptides AB in?
Oncopeptides AB (ONCO) is classified in the General sector (Diversified industry).
What exchange is ONCO listed on?
ONCO is listed on ST.
What is Oncopeptides AB's net margin?
Oncopeptides AB (ONCO) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.